Literature DB >> 23131029

Fungal infections associated with contaminated methylprednisolone in Tennessee.

Marion A Kainer1, David R Reagan, Duc B Nguyen, Andrew D Wiese, Matthew E Wise, Jennifer Ward, Benjamin J Park, Meredith L Kanago, Jane Baumblatt, Melissa K Schaefer, Brynn E Berger, Ellyn P Marder, Jea-Young Min, John R Dunn, Rachel M Smith, John Dreyzehner, Timothy F Jones.   

Abstract

BACKGROUND: We investigated an outbreak of fungal infections of the central nervous system that occurred among patients who received epidural or paraspinal glucocorticoid injections of preservative-free methylprednisolone acetate prepared by a single compounding pharmacy.
METHODS: Case patients were defined as patients with fungal meningitis, posterior circulation stroke, spinal osteomyelitis, or epidural abscess that developed after epidural or paraspinal glucocorticoid injections. Clinical and procedure data were abstracted. A cohort analysis was performed.
RESULTS: The median age of the 66 case patients was 69 years (range, 23 to 91). The median time from the last epidural glucocorticoid injection to symptom onset was 18 days (range, 0 to 56). Patients presented with meningitis alone (73%), the cauda equina syndrome or focal infection (15%), or posterior circulation stroke with or without meningitis (12%). Symptoms and signs included headache (in 73% of the patients), new or worsening back pain (in 50%), neurologic symptoms (in 48%), nausea (in 39%), and stiff neck (in 29%). The median cerebrospinal fluid white-cell count on the first lumbar puncture among patients who presented with meningitis, with or without stroke or focal infection, was 648 per cubic millimeter (range, 6 to 10,140), with 78% granulocytes (range, 0 to 97); the protein level was 114 mg per deciliter (range, 29 to 440); and the glucose concentration was 44 mg per deciliter (range, 12 to 121) (2.5 mmol per liter [range, 0.7 to 6.7]). A total of 22 patients had laboratory confirmation of Exserohilum rostratum infection (21 patients) or Aspergillus fumigatus infection (1 patient). The risk of infection increased with exposure to lot 06292012@26, older vials, higher doses, multiple procedures, and translaminar approach to epidural glucocorticoid injection. Voriconazole was used to treat 61 patients (92%); 35 patients (53%) were also treated with liposomal amphotericin B. Eight patients (12%) died, seven of whom had stroke.
CONCLUSIONS: We describe an outbreak of fungal meningitis after epidural or paraspinal glucocorticoid injection with methylprednisolone from a single compounding pharmacy. Rapid recognition of illness and prompt initiation of therapy are important to prevent complications. (Funded by the Tennessee Department of Health and the Centers for Disease Control and Prevention.).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131029      PMCID: PMC4669562          DOI: 10.1056/NEJMoa1212972

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  Safe preparation and administration of intravitreal bevacizumab injections.

Authors:  Beth Anne Frost; Marion A Kainer
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

2.  Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Domenico Motola; Ugo Moretti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

3.  Aspergillus meningitis in Sri Lanka--a post-tsunami effect?

Authors:  Padma S Gunaratne; Chandrika N Wijeyaratne; Harshalal R Seneviratne
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

4.  Prevalence of compounding in independent community pharmacy practice.

Authors:  Timothy B McPherson; Patrick E Fontane; Kelsey D Jackson; Kathleen S Martin; Tricia Berry; Rasma Chereson; Rhonda Bilger
Journal:  J Am Pharm Assoc (2003)       Date:  2006 Sep-Oct

Review 5.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Current challenges in the management of invasive fungal infections.

Authors:  Chih-Cheng Lai; Che-Kim Tan; Yu-Tsung Huang; Pei-Lan Shao; Po-Ren Hsueh
Journal:  J Infect Chemother       Date:  2008-04-30       Impact factor: 2.211

7.  An outbreak of Aspergillus meningitis following spinal anaesthesia for caesarean section in Sri Lanka: a post-tsunami effect?

Authors:  P S Gunaratne; C N Wijeyaratne; P Chandrasiri; S Sivakumaran; K Sellahewa; P Perera; R Fernando; J Wanigasinghe; S Jayasinghe; R Ranawala; M T M Riffsy; H R Seneviratne
Journal:  Ceylon Med J       Date:  2006-12

8.  Aspergillus meningitis and discitis from low-back procedures in an immunocompetent patient.

Authors:  A B Larson Kolbe; A M McKinney; A Tuba Karagulle Kendi; D Misselt
Journal:  Acta Radiol       Date:  2007-07       Impact factor: 1.990

9.  A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Authors:  Rebecca H Sunenshine; Esther T Tan; Dawn M Terashita; Bette J Jensen; Marilyn A Kacica; Emily E Sickbert-Bennett; Judith A Noble-Wang; Michael J Palmieri; Dianna J Bopp; Daniel B Jernigan; Sophia Kazakova; Eddy A Bresnitz; Christina G Tan; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2007-07-24       Impact factor: 9.079

10.  An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.

Authors:  F Jacobs; D Selleslag; M Aoun; A Sonet; A Gadisseur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-05       Impact factor: 3.267

View more
  66 in total

1.  Economic Evaluation of Fungal Meningitis Outbreak Response in New River Valley: Local Health Department Perspective.

Authors:  Kaja M Abbas; Nargesalsadat Dorratoltaj; Margaret L O'Dell; Paige Bordwine; Thomas M Kerkering; Kerry J Redican
Journal:  Front Public Health Serv Syst Res       Date:  2015-07

2.  Galactomannan testing for early diagnosis of Exserohilum rostratum infection.

Authors:  Maya Korem; Itzhack Polacheck; Ayelet Michael-Gayego; Jacob Strahilevitz
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

3.  Fungal disease following contaminated steroid injections: Exserohilum is ready for its close-up.

Authors:  Marta Feldmesser
Journal:  Am J Pathol       Date:  2013-07-19       Impact factor: 4.307

4.  Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Authors:  Alice S Weissfeld; Riya Augustin Joseph; Theresa V Le; Ernest A Trevino; M Frances Schaeffer; Paula H Vance
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

Review 5.  Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Authors:  Alice S Weissfeld
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

6.  CNS Mold Infections.

Authors:  Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2013-10-13       Impact factor: 3.725

7.  Emerging infections of the central nervous system.

Authors:  Jennifer Lyons; Justin McArthur
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

8.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

9.  Whole-genome analysis of Exserohilum rostratum from an outbreak of fungal meningitis and other infections.

Authors:  Anastasia P Litvintseva; Steven Hurst; Lalitha Gade; Michael A Frace; Remy Hilsabeck; James M Schupp; John D Gillece; Chandler Roe; David Smith; Paul Keim; Shawn R Lockhart; Shankar Changayil; M Ryan Weil; Duncan R MacCannell; Mary E Brandt; David M Engelthaler
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

10.  Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections.

Authors:  Lalitha Gade; Christina M Scheel; Cau D Pham; Mark D Lindsley; Naureen Iqbal; Angela Ahlquist Cleveland; Anne M Whitney; Shawn R Lockhart; Mary E Brandt; Anastasia P Litvintseva
Journal:  Eukaryot Cell       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.